Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This is an online event only. Register here.

In this paper, I respond to two sets of objections that have been raised against expanding state-funded fertility treatment provision for existing treatments, such as IVF, and against funding new treatments, such as uterine transplantation (UTx). Both IVF and UTx enable involuntary childless people to have genetically related children, something that, for many, is a valuable life project. The fulfilment of such a life project through fertility treatments is also what the two objections that I wish to discuss centre on. Following Emily McTernan, I refer to the first objection to expanding existing fertility treatment provision and to fund new treatments as the “one good among many” objection. It purports that it is unjustifiable for the state to prioritise funding such treatments over funding that could enable citizens to fulfil their preferred life project. Fertility treatments are one good among the many that the state could provide to citizens to fulfil their diverse and valuable life projects. The second is what, following Mianna Lotz, I refer to as the “treatment-reform compatibility” objection. It asserts that efforts aimed at dismantling putatively oppressive norms concerning the value of genetic relatedness and at making adoption more accessible are incompatible with efforts to fund new fertility treatments. I will argue that whilst these objections raise important concerns, they do not represent defeating arguments against expanding fertility treatment provisions and providing funding for new treatments. My contention—and the approach that I advocate for—is that people’s, and especially women’s reproductive preferences should be given more weight in discussions concerning fertility treatment provision, due to the costs associated with disregarding them. Additionally, I suggest that there is both practical and conceptual compatibility between enabling the fulfilment of one vis-à-vis another valuable life project, and between challenging oppressive norms and satisfying people’s preferences.

Richard Doll seminars IN Public health and epidemiology

 Richard Doll

Forthcoming events

Infectious Disease Seminar Series: Evolutionary drivers of antibiotic resistance in pathogen populations

Monday, 03 October 2022, 1pm to 2pm @ BDI/OxPop Building Seminar Room LG 0-1, Old Road Campus, Headington, OX3 7LF

What is new in Polygenic Risk Scores?

Tuesday, 11 October 2022, 1pm to 2pm

Infectious Disease Seminar Series: Lessons learned - Will suffering through one pandemic help prevent another?

Monday, 17 October 2022, 1pm to 2pm @ Big Data Institute / OxPop Building, Old Road Campus, Headington, OX3 7LF

Infectious Disease Seminar Series: Global molecular epidemiology of HIV-1

Monday, 31 October 2022, 1pm to 2pm @ BDI Seminar Room LG 0-1, Old Road Campus, Headington, OX3 7LF

Infectious Disease Seminar Series: COVID-19 and Kids: what have we learnt after 3 years?

Monday, 07 November 2022, 1pm to 2pm @ BDI Seminar Room LG 1, Old Road Campus, Headington, OX3 7LF